Jinghua Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 55.7% in First Three Quarters of 2022
Listen to the full version

Jinghua Pharmaceutical Group Co.,Ltd. (精华制药集团股份有限公司) (002349.SZ) reported a net profit of 189.4 million yuan in the first three quarters of 2022, up 55.7% year-on-year.
Meanwhile, the company posted 1.2 billion yuan in revenue, up 21.3% year-on-year.
At the end of the reporting period, it had 3.2 billion yuan in total assets and 492 million yuan in total liabilities, with a liability-to-asset ratio of 15.4%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR